A comparative analysis of NLRP3-related inflammatory mediators in synovial fluid in temporomandibular joint osteoarthritis and internal derangement
- PMID: 33637064
- PMCID: PMC7913283
- DOI: 10.1186/s12891-021-04092-0
A comparative analysis of NLRP3-related inflammatory mediators in synovial fluid in temporomandibular joint osteoarthritis and internal derangement
Abstract
Background: The nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome signaling pathway is a highlighted topic in the field of inflammation. However, there is little research on the relationship between the NLRP3 inflammasome pathway and temporomandibular joint osteoarthritis (TMJOA). The aim of this study was to examine the expression of inflammatory mediators related to the NLRP3 inflammasome in the synovial fluid of patients with condylar cartilage degeneration and verify the clinical effects of sodium hyaluronic acid (HA) treatment on TMJOA.
Methods: Patients diagnosed with temporomandibular joint internal derangement (TMJID) without condylar defects and TMJOA with condylar defects were divided into two groups. There were thirty patients in each group, and inflammatory mediators related to the NLRP3 inflammasome, including interleukin-1 beta (IL-1β), IL-18, NLRP3, and cysteinyl aspartate specific proteinase 1 (CASP1), in synovial fluid were measured by enzyme-linked immunosorbent assay (ELISA). Eighteen patients in the TMJOA group were retested after two HA treatments to evaluate the therapeutic effects of HA.
Results: IL-1β, IL-18, NLRP3 and CASP1 were all positive in the two groups, and TMJOA patients with condylar defects had higher expression of these molecules than TMJID patients (P < 0.05). IL-1β, IL-18, and NLRP3 were decreased after two HA treatments (P<0.05), but there was no significant difference in CASP1 after two HA injections (P = 0.549).
Conclusions: The NLRP3 inflammasome signaling pathway may be involved in condylar degeneration. HA could reduce some inflammatory molecules to alleviate inflammation.
Keywords: Condylar degeneration; Hyaluronic acid; NLRP3; Temporomandibular joint osteoarthritis.
Conflict of interest statement
None.
Figures



Similar articles
-
Association of HMGB1 levels in synovial fluid with the severity of temporomandibular joint osteoarthritis.BMC Musculoskelet Disord. 2023 Mar 11;24(1):183. doi: 10.1186/s12891-023-06208-0. BMC Musculoskelet Disord. 2023. PMID: 36906519 Free PMC article.
-
Targeting NLRP3 Inflammasome Alleviates Synovitis by Reducing Pyroptosis in Rats with Experimental Temporomandibular Joint Osteoarthritis.Mediators Inflamm. 2022 Nov 23;2022:2581151. doi: 10.1155/2022/2581151. eCollection 2022. Mediators Inflamm. 2022. PMID: 36466156 Free PMC article.
-
Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.Mol Neurobiol. 2016 Jul;53(5):3462-3476. doi: 10.1007/s12035-015-9242-y. Epub 2015 Jun 20. Mol Neurobiol. 2016. PMID: 26091790
-
NLRP3 as a potentially novel biomarker for the management of osteoarthritis.Osteoarthritis Cartilage. 2018 May;26(5):612-619. doi: 10.1016/j.joca.2018.02.901. Epub 2018 Mar 2. Osteoarthritis Cartilage. 2018. PMID: 29499288 Review.
-
An Updated View on Temporomandibular Joint Degeneration: Insights from the Cell Subsets of Mandibular Condylar Cartilage.Stem Cells Dev. 2022 Aug;31(15-16):445-459. doi: 10.1089/scd.2021.0324. Epub 2022 Feb 18. Stem Cells Dev. 2022. PMID: 35044232 Review.
Cited by
-
Senkyunolide A inhibits the progression of osteoarthritis by inhibiting the NLRP3 signalling pathway.Pharm Biol. 2022 Dec;60(1):535-542. doi: 10.1080/13880209.2022.2042327. Pharm Biol. 2022. PMID: 35225151 Free PMC article.
-
Potential pathological and molecular mechanisms of temporomandibular joint osteoarthritis.J Dent Sci. 2023 Jul;18(3):959-971. doi: 10.1016/j.jds.2023.04.002. Epub 2023 Apr 18. J Dent Sci. 2023. PMID: 37404608 Free PMC article. Review.
-
Efficacy of hyaluronic acid in temporomandibular disorders evaluated with diagnostic criteria for temporomandibular disorders (DC/TMD).J Oral Rehabil. 2025 Feb;52(2):254-265. doi: 10.1111/joor.13840. Epub 2024 Aug 29. J Oral Rehabil. 2025. PMID: 39210692 Free PMC article. Review.
-
Emerging role of mesenchymal stem/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier.Eur J Med Res. 2023 Feb 20;28(1):86. doi: 10.1186/s40001-023-01034-5. Eur J Med Res. 2023. PMID: 36803566 Free PMC article. Review.
-
Targeting inflammasome-dependent mechanisms as an emerging pharmacological approach for osteoarthritis therapy.iScience. 2022 Nov 11;25(12):105548. doi: 10.1016/j.isci.2022.105548. eCollection 2022 Dec 22. iScience. 2022. PMID: 36465135 Free PMC article. Review.
References
-
- de Paiva Bertoli FM, Bruzamolin CD, de Almeida Kranz GO, Losso EM, Brancher JA, de Souza JF. Anxiety and malocclusion are associated with temporomandibular disorders in adolescents diagnosed by RDC/TMD. A cross-sectional study. J Oral Rehabil. 2018;45(10):747–755. doi: 10.1111/joor.12684. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous